Content about Disaster

October 21, 2013

Nearly 1-in-50 people in the United States are at risk of severe allergic reactions, according to a new study announced Monday by the Asthma and Allergy Foundation of America.

WASHINGTON — Nearly 1-in-50 people in the United States are at risk of severe allergic reactions, according to a new study announced Monday by the Asthma and Allergy Foundation of America.

According to the study, severe, life-threatening allergic reactions known as anaphylaxis are common in the United States, occurring in about 1.6% of the population. The rate, the study said, is probably higher, and closer to 5.1%. The study was published in the Journal of Allergy and Clinical Immunology.

October 16, 2013

Contrary to the pharmaceutical industry’s commonly-held belief that active Rx and OTC brand consumers are harder to find online than offline, a new study released Tuesday reveals that the online audience is just as active — and for select categories, more active — than the general population.

NEW YORK — Contrary to the pharmaceutical industry’s commonly-held belief that active Rx and OTC brand consumers are harder to find online than offline, a new study released Tuesday reveals that the online audience is just as active — and for select categories, more active — than the general population.

October 14, 2013

The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

NEW YORK — The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

September 27, 2013

Congress is expected to pass the Drug Quality and Security Act, which would subject sterile compounding pharmacies to stronger federal regulations and has attracted support from an independent pharmacy trade group, compared with a previous effort at federal regulations of compounding, Senate Bill 959, which many pharmacists feared would threaten their businesses and patients' access to compounded drugs. The efforts to place compounding pharmacies under federal regulations stem from last year's scandal in which many patients died and more were sickened after taking injected steroids contaminated with fungus.

The bills' purpose is simple enough: protecting the safety of patients by preventing irresponsible pharmacies like the New England Compounding Center from slipping through the cracks. But the older bill attracted opposition from independent pharmacies because, despite its good intentions, forced them to make costly changes to their business models or force them out of compounding altogether.

Congress is expected to pass the Drug Quality and Security Act, which would subject sterile compounding pharmacies to stronger federal regulations and has attracted support from an independent pharmacy trade group, compared with a previous effort at federal regulations of compounding, Senate Bill 959, which many pharmacists feared would threaten their businesses and patients' access to compounded drugs.

September 26, 2013

Legislation to allow the Food and Drug Administration to strengthen its regulatory powers over compounding pharmacies is expected to pass both houses of Congress after committees agreed on it Thursday, according to published reports.

NEW YORK — Legislation to allow the Food and Drug Administration to strengthen its regulatory powers over compounding pharmacies is expected to pass both houses of Congress after committees agreed on it Thursday, according to published reports.

September 25, 2013

W.S. Badger Co. has announced that it is voluntarily recalling all lots of its 4-oz. SPF 30 Baby Sunscreen Lotion and one lot of its 4-oz. SPF 30 Kids Sunscreen Lotion due to microbial contamination.

NEW YORK — W.S. Badger Co. has announced that it is voluntarily recalling all lots of its 4-oz. SPF 30 Baby Sunscreen Lotion and one lot of its 4-oz. SPF 30 Kids Sunscreen Lotion due to microbial contamination.

September 23, 2013

The Food and Drug Administration will not enforce regulatory requirements for most mobile medical apps because they "post minimal risk to consumers," the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration will not enforce regulatory requirements for most mobile medical apps because they "post minimal risk to consumers," the agency said Monday.

The FDA announced the issuance of guidance on the apps, saying it would adopt a "tailored policy" toward regulation, focusing its regulatory oversight on those apps that present greater risk if they do not work as intended.

September 13, 2013

Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

SILVER SPRING, Md. — Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

The agency announced new labeling changes and regulatory requirements for makers of extended-release and long-acting opioids, citing the risk the drugs carry of overdose, abuse and withdrawal. In response, a group also cautioned consumers to be careful when using non-steroidal anti-inflammatory drugs.

September 10, 2013

Financial firm Deloitte recently leveraged a gamification platform, called Badgeville, to augment its Deloitte Leadership Academy, a digital executive training program that's deployed across 50,000 executives at more than 150 companies. The gamification elements included ranks and rewards to be showcased in participant profiles, missions and leaderboards.

Financial firm Deloitte recently leveraged a gamification platform, called Badgeville, to augment its Deloitte Leadership Academy, a digital executive training program that's deployed across 50,000 executives at more than 150 companies. The gamification elements included ranks and rewards to be showcased in participant profiles, missions and leaderboards.

August 14, 2013

In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States.

BASKING RIDGE, N.J. — Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan, today announced a second year of its EpiPen4Schools program. In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States. Qualifications include having a valid prescription.

August 8, 2013

Boiled down to its essence, the key question for Diplomat, said VP clinical services Gary Rice, is "how do we maximize the patient's experience?"

Ask any of the roughly 900 people who work for Diplomat Specialty Pharmacy what the company is best known for, and you might get a variety of answers: creating a patient-centric, information-driven business model that merges effective clinical care and patient outcomes with lower costs for patients and payers; giving retail pharmacies the resources to compete in the specialty pharmacy arena; or boosting average patient adherence rates to 90% and above through effective management of patients, drug utilization data and out-of-pocket costs.

August 2, 2013

U.S. Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., on Thursday introduced legislation that would retool the labeling requirements for dietary supplement manufacturers, require pre-market certification on new products and require successful efficacy trials.

WASHINGTON — U.S. Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., on Thursday introduced legislation that would retool the labeling requirements for dietary supplement manufacturers, require pre-market certification on new products and require successful efficacy trials. The legislation also was written to better deliniate regulatory requirements for dietary supplements vs. food. 

The bill is not supported by industry.

July 25, 2013

The NPD Group, which tracks prestige beauty, has reported that sales of makeup and skin care with SPF reached $1.1 billion in U.S. prestige department stores from June 2012 to May 2013, a 24% increase from three years ago.

PORT WASHINGTON, N.Y. — The NPD Group, which tracks prestige beauty, has reported that sales of makeup and skin care with SPF reached $1.1 billion in U.S. prestige department stores from June 2012 to May 2013, a 24% increase from three years ago.

“Whether it is health concerns, or a more superficial fear of looking older, the intensified focus on sun protection from the beauty and healthcare industries is having a real impact on consumers and the market,” stated Karen Grant, VP and senior global industry analyst for the NPD Group.

July 18, 2013

The two groups announced that the outing would take place at the Strategic Business Exchange, set to take place Oct. 14 to 16 in San Antonio. The PAN Foundation offers funding to patients with life-threatening illnesses who are underinsured.

ALEXANDRIA, Va. — The National Association of Specialty Pharmacy and the Patient Access Network Foundation will sponsor a charity golf outing in the fall.

The two groups announced that the outing would take place at the Strategic Business Exchange, set to take place Oct. 14-16 in San Antonio. The PAN Foundation offers funding to patients with life-threatening illnesses who are underinsured.

July 15, 2013

Boulder Brands, Inc. announced it had acquired 80% of GlucoBrands, owner of Level Life Foods. Based in Colorado, Level is a growing company, approaching $1 million in sales that provides products to help in the daily management of diabetes.

BOULDER, Colo. — Boulder Brands, Inc. announced last week it  had acquired 80% of GlucoBrands, LLC, owner of Level Life Foods. Based in Colorado, Level is a growing company, approaching $1 million in sales, which provides products to help in the daily management of diabetes.

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

June 26, 2013

Health kiosks made by SoloHealth and placed in Sam's Club stores will have a new feature installed to allow users to assess their needs for vitamins and supplements.

ATLANTA — Health kiosks made by SoloHealth and placed in Sam's Club stores will have a new feature installed to allow users to assess their needs for vitamins and supplements.

The company said its SoloHealth Station kiosks at stores operated by the club retailer would include a Vitamin Assessment module. The module will only be installed on Sam's Club's kiosks, the company said. The kiosks also include screenings for vision, blood pressure, weight and body mass index.

June 25, 2013

The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.

NOVATO, Calif. — The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.

June 18, 2013

A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.

BASKING RIDGE, N.J. — A division of Mylan is hiring NFL player Adrian Peterson and celebrity nanny Jo Frost to promote an emergency treatment for severe allergic reactions.

Mylan Specialty announced that it had hired the two — who both have potentially life-threatening allergies — to raise awareness of the problem. Mylan Specialty is launching a multichannel marketing campaign for the EpiPen (epinephrine) auto-injector to mark the 25th anniversary of its approval by the Food and Drug Administration.

June 3, 2013

Efforts to create a generic top-level domain for legitimate pharmacy websites gained traction last week when the Internet Corporation for Assigned Names and Numbers, or ICANN - the body that controls what goes into Internet URLs - gave the National Association of Boards of Pharmacy a passing grade for an initial evaluation of its plans for the domain, ".pharmacy."

If successful, the .pharmacy domain will create a powerful new weapon to combat the rise of illegal online pharmacies, which, according to many studies, constitute all but 3% of the websites selling drugs on the Internet. These are the "Canadian" pharmacies selling cheap drugs that one often sees links to on search engines and other websites; despite their supposed provenance, they're usually based in countries where regulations are lax or unenforced.

Efforts to create a generic top-level domain for legitimate pharmacy websites gained traction last week when the Internet Corporation for Assigned Names and Numbers, or ICANN — the body that controls what goes into Internet URLs — gave the National Association of Boards of Pharmacy a passing grade for an initial evaluation of its plans for the domain ".pharmacy."

May 30, 2013

Beauty trends are as much a reflection of the consumer's state of mind as they are a reflection of the technological innovations put forth by research-and-development teams at laboratories around the world. While consumers are not able to verbalize their expectations for the ideal product that will fulfill their needs, they are able to pinpoint gaps with their unmet needs through their purchasing patterns.

GUEST COLUMN BY DANIELA CIOCAN

Beauty trends are as much a reflection of the consumer's state of mind as they are a reflection of the technological innovations put forth by research-and-development teams at laboratories around the world. While consumers are not able to verbalize their expectations for the ideal product that will fulfill their needs, they are able to pinpoint gaps with their unmet needs through their purchasing patterns. These shopping patterns allow marketing teams and product developers to gauge consumer readiness for the next innovation.

May 29, 2013

An effort to allow trusted online pharmacies to add ".pharmacy" to their URLs cleared a hurdle last week as it passed an initial evaluation by the body that regulates the web address suffixes, known as generic top-level domains.

NEW YORK — An effort to allow trusted online pharmacies to add ".pharmacy" to their URLs cleared a hurdle last week as it passed an initial evaluation by the body that regulates the web address suffixes, known as generic top-level domains.

May 21, 2013

A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.

BASKING RIDGE, N.J. — A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.

Mylan Specialty announced the Raise Your Hand for Anaphylaxis Awareness campaign, hiring actress Julie Bowen as a celebrity spokeswoman. The campaign will invite people to virtually "raise their hands" for their school districts by visiting www.Anaphylaxis101.com; four winning school districts will receive grants of $15,000 to support educational programs.

May 17, 2013

More than two-thirds of patients with hepatitis C achieved sustained virologic response or cure after completing newer “triple therapy” treatment, according to a Walgreens Specialty Pharmacy study released Friday.

DEERFIELD, Ill. — More than two-thirds of patients with hepatitis C achieved sustained virologic response or cure after completing newer “triple therapy” treatment, according to a Walgreens Specialty Pharmacy study released Friday. 

May 10, 2013

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

SAN DIEGO — A biotech company and a nonprofit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

The ALS Emergency Treatment Fund and Denovo Biomarkers announced Friday a deal to explore the use of personalized medicine in treating patients with the disease, known medically as amyotrophic lateral sclerosis. The two said the approach could accelerate drug development in ALS and other life-threatening disorders.